Endpoint definition
↥| Name | PULM_PNEUMONIA_SEPSIS |
|---|---|
| Long name | COPD/asthma/ILD related pneumonia or pneumonia derived septichaemia |
| Include | PNEUMONIA, SEPTICHE_PNEUMONIA |
| First defined in version | DF2 |
COPD/asthma/ILD related pneumonia or pneumonia derived septichaemia
pneumonia: An acute, acute and chronic, or chronic inflammation focally or diffusely affecting the lung parenchyma, due to infections (viruses, fungi, mycoplasma, or bacteria), treatment (e.g. radiation), or exposure (inhalation) to chemicals. Symptoms include cough, shortness of breath, fevers, chills, chest pain, headache, sweating, and weakness.
Summary Statistics
↥Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 27715 | 12635 | 15080 |
| Unadjusted prevalence (%) | 12.77 | 10.29 | 16.02 |
| Mean age at first event (years) | 53.80 | 52.17 | 55.17 |
| Case fatality at 5-years (%) | 15.79 | 12.08 | 18.89 |
Longitudinal metrics
| All | Female | Male | |
|---|---|---|---|
| Median nb. of events per indiv. | 1.0 | 1.0 | 1.0 |
| Recurrence at 6 months (%) | 15.02 | 14.10 | 15.79 |
Survival analyses between endpoints
↥Plot
before COPD/asthma/ILD related pneumonia or pneumonia derived septichaemia
after COPD/asthma/ILD related pneumonia or pneumonia derived septichaemia
Loading survival analyses plot…
Table
Loading survival analyses table…